New device aims to tighten skin safely in all skin types
NCT ID NCT07224880
First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study is testing a device called Ellacor that uses tiny needles to remove small pieces of skin, aiming to reduce wrinkles and tighten loose skin on the face and belly. Researchers want to see if it works safely in people with different skin tones and in those taking GLP-1 medications (like Ozempic) for weight loss. Ten adults aged 30-65 will be followed for 90 days to check results and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP1 AGONIST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tri Valley Plastic Surgery
RECRUITINGDublin, California, 94568, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.